Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-04-19
1995-06-27
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530356, C08L 8906, A61L 1500, A61F 200, A61B 1900
Patent
active
054280249
ABSTRACT:
High concentration collagen compositions having improved persistence when administered for soft tissue augmentation are prepared from both cross-linked and non-cross-linked collagen starting materials. Suspensions of the starting materials are subjected to vigorous mechanical disruption to reduce the average collagen fiber size to below a threshold level which enhances the injectability of the composition. Thus, both enhanced injectability and enhanced persistence may be achieved using the same formulations.
REFERENCES:
patent: 3949073 (1976-04-01), Daniels et al.
patent: 4424208 (1984-01-01), Wallace et al.
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4803075 (1989-02-01), Wallace et al.
McPherson et al. (1988) J. Dermatol. Surg. Oncol. 14 (suppl 1) 7 Jul.
Chu George
Rao Prema
Trobaugh Brenda
Collagen Corporation
Schain Howard E.
Touzeau Lynn
LandOfFree
High concentration homogenized collagen compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High concentration homogenized collagen compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High concentration homogenized collagen compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-287579